Shanghai Bao Pharmaceuticals Co., Ltd.
Shanghai Bao Pharmaceuticals Co., Ltd. (HKSE: 2659) is trading at HK$12.37, about ₹151 at today's HKD/INR rate, as of 30 Sep 2026, 3:30 AM ET, up 0.16% today. Indian residents can buy Shanghai Bao Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$12.20
Today's high
HK$13.00
52 week low
HK$12.02
52 week high
HK$206.00
2659 opened at HK$13.00, closed previously at HK$12.35, and has traded between HK$12.02 and HK$206.00 over the past 52 weeks.
About
Shanghai Bao Pharmaceuticals Co., Ltd., a biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China. The company uses synthetic biology technology to develop and deliver recombinant biologic drugs. Its products include KJ017, a recombinant human hyaluronidase for subcutaneous drug delivery; KJ103, a recombinant immunoglobulin G (IgG)-degrading enzyme for IgG-mediated autoimmune diseases; and SJ02, a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH CTP) for assisted reproduction. The company also develops KJ101, a recombinant human chymotrypsin developed through synthetic biology that is in Phase 2 clinical trials; KJ015, a bispecific anti HER2 antibody; BJ007, a subcutaneous formulation of ceftriaxone sodium for the treatment of bacterial infections; BJ009, a first generation cephalosporin antibiotic for treating bacterial infections, including of the skin, bones, joints, reproductive organs, blood, heart valves, respiratory tract, biliary tract, and urinary tract; and SJ04, a recombinant human chorionic gonadotropin (hCG) that can be used in assisted reproductive procedures to accelerate follicle maturation and induce ovulation. These product candidates are in Phase 1 clinical trials. In addition, it is developing BJ045, a subcutaneously administered anti CD20 antibody; BJ047, a subcutaneously administered anti CD154 antibody; BJ008, a subcutaneous formulation of cefoperazone sodiumsulbactam sodium to treat bacterial infections; and BJ044, a serine protease inhibitor with broad anti inflammatory properties. These product candidates are in the preclinical stage. Further, the company licenses its intellectual property and other deliverables and provides technical services. Shanghai Bao Pharmaceuticals Co., Ltd. was founded in 2019 and is based in Shanghai, China.
Key statistics
Avg. volume
2.67M
Market cap
HK$1.89B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
0.92
Dividend yield
—
Last dividend
HK$0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Shanghai Bao Pharmaceuticals from India
Indian residents can buy Shanghai Bao Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Shanghai Bao Pharmaceuticals and place an order
Find Shanghai Bao Pharmaceuticals by name or by its ticker, 2659, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Shanghai Bao Pharmaceuticals trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Shanghai Bao Pharmaceuticals position in HKD and INR. Shanghai Bao Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Shanghai Bao Pharmaceuticals from India
Trading and taxes when buying Shanghai Bao Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneShanghai Bao Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Shanghai Bao Pharmaceuticals stock?
Yes. Shanghai Bao Pharmaceuticals (2659) has been listed on the Hong Kong Stock Exchange since 2025, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Shanghai Bao Pharmaceuticals share cost in rupees?
One Shanghai Bao Pharmaceuticals share is HK$12.37 — about ₹151 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Shanghai Bao Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Shanghai Bao Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Shanghai Bao Pharmaceuticals?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Shanghai Bao Pharmaceuticals shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shanghai Bao Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Shanghai Bao Pharmaceuticals pay a dividend?
No. Shanghai Bao Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Shanghai Bao Pharmaceuticals from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Shanghai Bao Pharmaceuticals a Hong Kong SAR China company, and does that change how it is taxed?
Shanghai Bao Pharmaceuticals trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Shanghai Bao Pharmaceuticals trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Shanghai Bao Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Shanghai Bao Pharmaceuticals holding, its cost and its closing value.
How do I sell Shanghai Bao Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.